Coronavirus: Antimalarial drug rolled out in US after ‘promising research’
As many as 4000 seriously ill coronavirus patients in New York are being treated with an antimalarial drug, health officials say.
As many as 4000 seriously ill coronavirus patients in New York are being treated with the antimalarial drug hydroxychloroquine, state health officials say.
President Donald Trump has touted hydroxychloroquine as a potential lifesaver, although there is no widespread scientific evidence to date showing it helps battle COVID-19.
But New York Governor Andrew Cuomo last month said healthcare providers in the state would be using the drug in combination with the antibiotic Zithromax, or azithromycin, for some last-ditch cases, based on potentially promising research.
“Time is of the essence,’’ said Albany University public health dean David Holtgrave, who is on the state’s research team.
A state Health Department official said the department had shipped doses of hydroxychloroquine to 56 hospitals across New York, distributing enough “to treat 4000 patients to date”.
The New York Post
A terrifying new reality: Will Israel become a Sparta of the Middle East, at war for years?
One year after the brutal Hamas attack that ended Israel’s two-decade golden age of relative peace, expanding wealth and growing diplomatic ties, the country is now firmly on the counter-attack and preparing to be at war for years.
Albanese’s foreign policy racked by cowardice and confusion on Israel
Either this Labor government supports Israel in its fight against Iran and the barbarism of Hezbollah and Hamas, or it doesn’t.